Medivir, GlaxoSmithKline enter co-promotion agreement

Stockholm, Sweden

- Medivir has entered into a co-promotion agreement with the Swedish subsidiary of GlaxoSmithKline, according to Earthtimes.org.

The agreement will allow Medivir to co-promote some GlaxoSmithKline products on the Swedish market, such as the companies entire dermatology portfolio, including the eczema and psoriasis drug Betnovat.

The magnitude of revenue for Medivir is based on the degree that future sales exceed an agreed baseline, Earthtimes reports.